ML335
CAS No. 825658-06-8
ML335( ML335 | ML-335 | ML 335 | TREK-1/2 Activator )
Catalog No. M17606 CAS No. 825658-06-8
ML335 is a selective activator of both TREK-1 and TREK-2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 54 | In Stock |
|
| 2MG | 34 | In Stock |
|
| 5MG | 54 | In Stock |
|
| 10MG | 91 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 276 | In Stock |
|
| 100MG | 415 | In Stock |
|
| 200MG | 600 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML335
-
NoteResearch use only, not for human use.
-
Brief DescriptionML335 is a selective activator of both TREK-1 and TREK-2.
-
DescriptionML335 is a potent and selective TREK-1/2 Activator. ML335 is an agonist for OPRM1-OPRD1 heterdimerization with an EC50 of 403 nM, and selectivities vs. OPRM1, OPRD1, and HTR5A of 37, 2.7, and >99, respectively.
-
In VitroXenopus oocyte two-electrode voltage-clamp measurements show that ML335 and ML402 activate K2P2.1 and K2P10.1 but not K2P4.1 (14.3±2.7?μM, K2P2.1-ML335; 13.7±7.0?μM, K2P2.1-ML402; 5.2±0.5?μM, K2P10.1-ML335; and 5.9±1.6?μM, K2P10.1-ML402). Swapping the Lys271 equivalent between K2P2.1 and K2P4.1 results in a clear phenotype reversal for ML335 and M402 activation. ML335 and ML402 activate K2P2.1 in HEK293 cells similar to their effects in Xenopus oocytes (5.2±0.8?μM and 5.9±1.6?μM for ML335 and ML402, respectively (n≥3)).
-
In Vivo——
-
SynonymsML335 | ML-335 | ML 335 | TREK-1/2 Activator
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorTREK-1| TREK-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number825658-06-8
-
Formula Weight373.25
-
Molecular FormulaC15H14Cl2N2O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 155 mg/mL. 415.27 mM;
-
SMILESCS(=O)(=O)Nc1ccc(cc1)C(=O)NCc1c(cc(cc1)Cl)Cl
-
Chemical NameN-[(2,4-Dichlorophenyl)methyl]-4-(methanesulfonamido)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Mibefradil dihydroch...
Mibefradil dihydrochloride is an blocker of calcium channel with moderate selectivity for T-type Ca2+ channels (T-type and L-type currents with IC50s of 2.7 μM and 18.6 μM, respectively). Mibefradil dihydrochloride inhibits reversibly the T- and L-type currents with IC50 values of 2.7 and 18.6 μM, respectively.
-
(±)-Liquiritigenin
(±)-Liquiritigenin ((±)-4',7-Dihydroxyflavanone), a flavonoid extracted from Angelica keiskei, inhibits the calcium-activated chloride channel TMEM16A.(±)-Liquiritigenin induces an increase in apoptosis and an enhancement of caspase3 activity.
-
Ticolubant
Ticolubant is orally active leukotriene B4 antagonist with high affinity for the human neutrophil LTB4 receptor (Ki = 0.78 nM), blocks LTB4-induced Ca2+ migration with an IC50 of 6.6 ± 1.5 nM, and shows topical anti-inflammatory activity in a mouse model of skin inflammation.
Cart
sales@molnova.com